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Abstract: Opportunistic cytomegalovirus (CMV) infection is common in severely 
immunocompromised HIV-positive patients. The retina is the commonest site of involvement 
with hemorrhages a prominent feature. CMV retinitis affects 40% of HIV positive patients who 
have CD4 count of less than 100 cell/mm3, and in these circumstances clinicians are likely to 
consider commencing anti-CMV therapy without considering other causes. We report a man 
with HIV who developed bilateral retinal hemorrhages and ischemic maculopathy in associa-
tion with zidovudine (AZT)-induced anemia. Retinal hemorrhages resolved following blood 
transfusion.
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Opportunistic cytomegalovirus (CMV) infection is common in severely immunocom-
promised HIV-positive patients. The retina is the commonest site of involvement with 
hemorrhages a prominent feature (Sarraf and Ernest 1996; Vrabec 2004). CMV retinitis 
affects 40% of HIV positive patients who have CD4 count of less than 100 cell/mm3, 
and in these circumstances clinicians are likely to consider commencing anti-CMV 
therapy without considering other causes (Cunningham and Margolis 1998). We 
report a man with HIV who developed bilateral retinal hemorrhages and ischemic 
maculopathy in association with zidovudine (AZT)-induced anemia.
Case report
A 41-year-old Caucasian homosexual man, HIV-positive since 1992, presented with oral 
hairy leucoplakia. Hematological indices were; CD4 113 cells/mm3, hemoglobin (Hb) 
13.3 g/dl, WBC 3.8 × 109/l, and platelets 91 × 109/l. HIV RNA level was 35,000 copies/
ml. The combination of zidovudine, lamivudine, and efavirenz was commenced.
Having defaulted, he re-presented ten weeks later with acute shortness of breath 
and lethargy. Examination revealed pallor but no purpura, with Hb 3.2, WBC 1.7, 
and platelets 54. Serum B12, folate, and ferritin were normal. Syphilis and Parvovi-
rus antibodies were negative. He also complained of a sub-acute painless decrease in 
vision affecting his right eye. Visual acuities were 6/60 right and 6/6 left. Fundoscopy 
revealed bilateral signs of retinal ischemia with deep “blot” retinal haemorrhages, 
cotton wool spots and a foveal premacular hemorrhage (Figure 1). Ophthalmic ﬁ  nd-
ings were otherwise normal.
Following transfusion, hemoglobin was 11.2, WBC 1.9, and platelets 40. CMV 
PCR was negative for a venous blood sample.
His anemia was attributed to zidovudine which was stopped. Improvement of visual 
acuity and retinal features ensued (Figure 2). One year later visual acuities were 6/6 
right and left with signiﬁ  cantly improved normal retinal appearances.Clinical Ophthalmology 2008:2(1) 238
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Discussion
CMV retinitis may cause blindness and prompt therapy 
is indicated. Presenting features include painless visual 
deterioration, visual ﬁ  eld defects, retinal hemorrhages, and 
associated pale areas of opaque retina (Cunningham and 
Margolis 1998; Vrabec 2004). Other typical features of CMV 
retinitis which may help in differential diagnosis include an 
initially unilateral presentation, starting in the retinal periph-
ery with areas of hemorrhage and adjacent inﬁ  ltrate giving 
rise to the so-called “cheese pizza” appearance. Lesions tend 
to increase in extent in a contiguous fashion (“brush-ﬁ  re” 
spread). As more posterior retina becomes involved, atrophy 
and scarring develop in the previously inﬂ  amed areas. The 
vitreous is disproportionately uninﬂ  amed compared with the 
severity of the chorioretinal disease.
Retinal ﬁ  ndings may be decisive in the initiation of anti-
CMV therapy. But other conditions may also present with 
similar signs. Hemorrhagic retinopathy has been described 
with retinal venous occlusion in HIV-positive patients 
(Friedman and Margo 1995; Mansour et al 1996). Retinal 
hemorrhages as part of anemia associated ischemic retinopa-
thy have been reported in myeloproliferative disorder (Blood 
et al 1997) and pernicious anemia (Gupta et al 2001). These 
patients were HIV-negative. Beare and colleagues (2002) 
report two cases similar to ours in their survey of ocular 
disease in patients with tuberculosis and HIV presenting with 
fever in Africa. These individuals had hemoglobin of less 
than 4.0 g/dl and widespread retinal hemorrhages including 
many which were white-centred, as exhibited in our patient 
(Figure 1).
Ischemic maculopathy in HIV is recognized but uncom-
mon, and in most of such cases associated with CMV retinitis 
(Cunningham et al 2001). One of the serious adverse effects 
of AZT is anemia due to bone marrow suppression. It usually 
occurs within six weeks of initiation of therapy (Fischl et al 
1990). The only risk factor identiﬁ  ed for anemia in our patient 
was AZT therapy. Features of acute retinal ischemia include 
venous dilatation and beading, the presence of numerous 
retinal hemorrhages and cotton wool spots (CWS). CWS 
in microangiopathic HIV retinopathy tend to be small – our 
patient’s CWS were large, possibly reﬂ  ecting a greater degree 
of retinal ischemia (Mansour et al 1990).
Our patient showed no evidence of any other condi-
tion associated with retinal hemorrhages or ischemia. As 
in diabetic retinopathy, the vascular and other features of 
ischaemia may reverse following management – in our case 
by blood transfusion.
Clinicians should be aware of other causes of retinal 
hemorrhages in HIV-positive patients. Careful clinical 
examination and ophthalmic review facilitate appropriate 
management, avoiding costly and toxic anti-CMV treat-
ment. Patients commencing antiretroviral therapy should 
be counseled regarding the importance of close follow-up 
and supervision.
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